Sell Your Insurance Broker Business in the UK (2026): PE Buyers and BADR | CT Acquisitions
Start a Conversation

Sell Your Insurance Broker Business in the UK in 2026: PE Buyers, FCA Transfer, BADR

Sell Your Insurance Broker Business in the UK in 2026: PE Buyers, FCA Transfer, BADR

Selling your insurance broker business in the UK in 2026 involves country-specific mechanics that US-focused advisors miss. Companies House transfer notifications, HMRC BADR (Business Asset Disposal Relief) capital gains treatment, and FCA regulatory transfer requirements all shape both deal structure and after-tax proceeds. Multiples clear 8-14x EBITDA at platform scale where recurring commission book depth dominates. Named PE-backed acquirers include BRP Group UK, Hub International UK, Acrisure UK, Ardonagh, plus regional consolidators.

Insurance Agency business in the UK

If you operate an insurance broker business in the UK and you have searched “sell my insurance broker business in the UK”, the variables that drive your sale price are United Kingdom-specific in ways the broader category data does not capture. The named PE platforms with active deal posture in the UK in 2026, the EBITDA-tier multiples bands stated in £ GBP, the jurisdiction-specific tax-arbitrage structuring (which is the single largest after-tax lever any owner has), the regulator transfer procedure under HM Revenue & Customs (HMRC) and the relevant industry licensing body, and the 2024-2026 dated comparable transactions all reshape the multiple a buyer will pay. This page walks through the the UK valuation framework as insurance broker businesses are actually trading in mid-2026, the named buyers actively acquiring here, and the regulator transfer + tax structuring that determine net-of-tax proceeds.

CT Acquisitions runs sell-side M&A advisory mandates for owners of recurring-services businesses across the UK and the broader English-speaking market. The introductory conversation is confidential and NDA-protected. This page is the localised valuation framework for 🇬🇧 the UK insurance broker sellers, built from named-and-dated 2024-2026 transactional research rather than generic broker-listing rules of thumb.

The the UK insurance broker M&A landscape in 2026

The detailed market sizing, named-buyer table, EBITDA-tier multiples bands, regulator transfer procedure, jurisdiction-specific tax-arbitrage structuring, and 2024-2026 dated comparable transactions for the UK insurance broker are set out below. This section is the core valuation framework — everything else on the page is supporting context.

22. INSURANCE-AGENCY (UK)

1. Market Size & Structure

The UK general insurance distribution market is one of the largest and most mature broker channels in the world. The Association of British Insurers reports that UK general insurance premiums totalled £85.3 billion in 2024, with commercial lines accounting for roughly 56% and personal lines 44%. Brokers control approximately 53% of total UK general insurance distribution by gross written premium, with the share rising to over 80% in commercial lines, per London Economics analysis commissioned by BIBA in 2024. The British Insurance Brokers’ Association (BIBA) reports approximately 2,073 member firms representing over 95% of UK broker-placed premium, and the FCA Financial Services Register lists around 4,700 firms with general insurance intermediation permission as of Q1 2026.

The relevant Standard Industrial Classification (UK SIC 2007) is 66.22 Activities of insurance agents and brokers. ONS Inter-Departmental Business Register data for 2025 records approximately 8,930 enterprises under SIC 66.22, employing roughly 116,000 people, generating combined turnover north of £21 billion. The MGA channel sits under SIC 66.29 and accounts for an additional £11 billion of premium placed via 350+ managing general agents, per the Managing General Agents’ Association (MGAA) 2025 census.

Total addressable market for sell-side advisory work, defined as private UK brokers with EBITDA between £500k and £25 million, is concentrated around 1,800 to 2,200 trading entities. Insurance Times’ 2025 Top 50 Brokers ranking shows the top six brokers, namely Aon UK, Marsh McLennan UK, Howden Group, Ardonagh, Gallagher UK and Lockton, account for approximately £8.2 billion of combined UK GWP, while the long tail of independent commercial brokers each placing under £25 million in premium remains the structural fuel for roll-up activity.

Top 5 UK insurance distribution platforms by 2025 UK GWP (per Insurance Times Top 50 Brokers 2025 and company filings):

  1. Aon UK Limited is the UK arm of Aon plc (NYSE: AON). UK turnover of approximately £1.42 billion in FY24 per Companies House filings. Heavily corporate and large commercial focus.
  1. Marsh McLennan Agency UK consolidates Marsh Commercial and the UK regional middle-market network. Parent Marsh McLennan (NYSE: MMC) reported global revenue of $24.5 billion in FY24, with UK and Ireland a stated growth corridor.
  1. Howden Group Holdings is controlled by CVC Capital Partners (lead since 2021), GIC, Hg Saturn, Cinven and HPS Investment Partners following the December 2023 secondary buyout that valued the group at approximately $13.5 billion enterprise value. Group income exceeded $3.5 billion in FY25 per the 2025 annual report.
  1. The Ardonagh Group is owned by Madison Dearborn Partners with HPS Investment Partners, the Abu Dhabi Investment Authority (ADIA) and GIC as significant minority shareholders following the 2023 to 2024 refinancing rounds. Income for FY24 was reported at $1.99 billion, with adjusted EBITDA of $683 million on a 31% growth rate, per the Ardonagh investor pack circulated April 2025. Following the A$2.3 billion (£1.12 billion) acquisition of PSC Insurance Group completed January 2025, Ardonagh became one of the largest non-listed global brokers by retail income.
  1. Gallagher UK sits under Arthur J. Gallagher & Co (NYSE: AJG). The August 2025 close of the $13.45 billion AssuredPartners acquisition pulled an additional UK retail footprint into the group via AssuredPartners International.

2. PE Buyer Landscape

UK broker M&A is dominated by sponsor-backed consolidators. MarshBerry’s 2025 UK insurance distribution M&A report counted 105 announced UK broker transactions for the calendar year, a decline from the 173 deals in 2023, with private-equity-backed acquirers responsible for over 70% of disclosed activity.

UK lower mid-market PE sponsors active in broking:

Larger sponsor capital:

US strategic and PE scouts active in UK:

The structural buyer pool exceeds 25 active sponsor-backed UK consolidators, each with stated targets of 10 to 25 bolt-on transactions per year.

3. EBITDA-Tier Multiples Bands

UK broker multiples are anchored to recurring commission income, client retention rates (typically 88% to 94% for commercial commodity books, 95%+ for speciality), and the proportion of binder or delegated authority income, which commands a premium of 1 to 2 turns of EBITDA over retail commission.

Sub-£500k EBITDA (founder brokerage, single office, single producer dependency):

£500k to £1.5m EBITDA (regional commercial broker, 5 to 20 producers):

£1.5m to £3m EBITDA (multi-office regional consolidator, mixed retail / SME commercial):

£3m to £10m EBITDA (speciality broker, regional consolidator-of-consolidators):

£10m to £25m EBITDA (regional platform, sub-scale MGA, niche speciality):

£25m to £75m EBITDA (national broker, true speciality, MGA with capacity-provider relationships):

£75m+ EBITDA (top-six UK retail platform, Lloyd’s wholesale):

Critical structural points buyers will negotiate hard on:

4. Regulator Transfer & Licensing

The Financial Conduct Authority (FCA) is the sole conduct regulator for UK insurance distribution. Every transaction must clear two FCA gates: a Change in Control filing under Part XII of the Financial Services and Markets Act 2000 (FSMA 2000), and where applicable a Senior Managers and Certification Regime (SMCR) regulatory reference and approval cycle for incoming senior management functions.

Core regulatory framework:

Change in Control process under FSMA Part XII:

A “controller” is defined under section 422 FSMA as anyone holding 10% or more of shares or voting rights, or who can exercise significant influence. Any acquisition crossing 10%, 20%, 30% or 50% thresholds requires prior FCA approval. The FCA has a statutory 60-working-day assessment period from receipt of a complete s.178 notice. In practice, sponsor-led acquisitions of fully authorised UK brokers complete in 8 to 12 weeks from filing.

Appointed Representative regime:

Many smaller distributors operate as Appointed Representatives (ARs) of a principal firm under section 39 FSMA. Following PS22/11 (effective 8 December 2022), principals must maintain enhanced oversight and report annually on AR activity. AR transactions are commercially treated as a contractual novation rather than a Change in Control filing, but principal firms are increasingly cautious and many will trigger a section 178 review.

Post-completion integration risks:

Client money (CASS 5):

CASS 5 rules govern Insurance Broking Accounts and statutory trust structures. Most sell-side processes will engage independent CASS auditors to confirm reconciliation status and exclude IBA cash from the equity bridge. CASS breaches are a frequent source of post-completion warranty claims.

5. Tax Structuring & Arbitrage

The BADR cliff is the single most important deadline driving UK broker M&A timing in 2026.

Business Asset Disposal Relief (BADR) reduces the rate of Capital Gains Tax on qualifying disposals of trading business assets up to a £1 million lifetime cap. Under HMRC’s CG64174 manual and HM Treasury’s October 2024 Autumn Budget:

Standard CGT on non-BADR disposals remains 24% (for higher-rate taxpayers). The maximum BADR tax saving therefore reduces from £140,000 in 2025/26 to £60,000 in 2026/27 on the £1 million lifetime allowance.

Practical sequencing for a £10 million enterprise-value broker sale:

Investors’ Relief mirrors BADR’s rate path: 10% pre-6 April 2025, 14% to 5 April 2026, then 18% thereafter, but the lifetime cap was cut from £10 million to £1 million effective 30 October 2024 (Budget Day).

Substantial Shareholding Exemption (SSE) under Schedule 7AC TCGA 1992 fully exempts corporate gains on the disposal of a 10%+ trading subsidiary held for at least 12 months in the preceding 6 years. SSE is the standard relief used when a corporate holdco rather than an individual is selling. SSE is unchanged by the 2024 Budget.

Section 135 / Section 136 TCGA 1992 share-for-share rollover defers CGT on shares received in consideration. Critical for vendor rollover structures into PE platforms, particularly where the PE house wants the founder to roll into management equity (the “MIP” or sweet equity layer). The seller must demonstrate the transaction is for bona fide commercial reasons and not for tax avoidance, with HMRC clearance under section 138 TCGA available pre-deal.

SDLT (Stamp Duty Land Tax) is rarely material on a broker share sale since the asset base is overwhelmingly intangible. However, where freehold offices transfer with the trade, SDLT applies on the property element at non-residential rates up to 5% on consideration over £250,000.

Employee Ownership Trusts (EOT) sales under section 236H to 236U TCGA 1992 provide a 0% CGT charge on the seller’s proceeds where 51%+ of the company is transferred to an EOT for the benefit of all employees. Conditions tightened under Schedule 7 Finance (No.2) Act 2025 effective for disposals after 30 October 2024: the seller must demonstrate consideration does not exceed market value (independent valuation now required), and the seller cannot retain control via trustee appointments. EOT remains a viable Plan B for advice-led brokers where PE pricing is below founder reserve.

Enterprise Management Incentive (EMI) options under Schedule 5 ITEPA 2003 allow tax-advantaged share options for employees of trading companies with gross assets under £30 million and fewer than 250 full-time-equivalent staff. Most regional brokers below £25 million EBITDA qualify. Properly structured EMI exits can deliver BADR rates on the option gain.

Goodwill amortisation under Part 8 CTA 2009 is not deductible for corporation tax purposes for related-party goodwill acquired after April 2002 and most third-party goodwill acquired after 7 July 2015 (subject to the 6.5% deduction on IP linked to qualifying IP from April 2019). Buyers therefore typically structure as share acquisitions to preserve the seller’s CGT rate and avoid double tax in the buyer’s hands.

6. NSI Act 2021 + CMA merger review

National Security and Investment Act 2021 came into force on 4 January 2022. UK insurance broking is not within the 17 mandatory notification sectors under the NSI (Notifiable Acquisitions) Regulations 2021. However, the Investment Security Unit retains call-in powers for up to 5 years post-completion where national security concerns arise.

The most likely NSI flashpoint is where a UK broker writes Ministry of Defence, intelligence-agency, government or critical-national-infrastructure cyber or political-risk business, particularly Lloyd’s binder business with classified end-clients. The 2024 NSI Annual Report shows 41 notifications in financial services for the year, with 2 retail insurance distribution call-ins, both cleared without remedy.

CMA merger review under the Enterprise Act 2002 jurisdictional thresholds:

For sub-£70 million UK turnover broker bolt-ons, the CMA almost never engages. The share of supply test is the more relevant gate at platform level. The CMA reviewed the Howden / Aston Lark transaction under the share of supply test in 2022 and cleared at Phase 1 in December 2022. The CMA also reviewed the Brown & Brown / GRP transaction at the 2021/22 boundary without intervention.

For the £75m+ EBITDA platform transactions, parties should expect a 4 to 8 week pre-notification engagement with the CMA followed by either a Phase 1 fast-track (typical) or a Phase 2 in-depth investigation (rare for retail broking but possible for highly concentrated Lloyd’s wholesale niches).

FCA Change in Control filings run in parallel with any CMA review and the two regulators coordinate informally. PRA notification is not required for pure broker acquisitions but is required where the target group includes an authorised insurer or reinsurer.

7. Recent Transactions (2024 to 2026 named)

2024 deals:

2025 deals:

2026 deals (to mid-June):

MarshBerry’s UK Insurance Distribution M&A Report for Q4 2025 recorded 22 announced UK broker transactions in the quarter, the quietest Q4 since 2016, with the slowdown driven by elevated UK base rates (Bank of England base rate held at 4.50% through Q4 2025) and tighter financing terms from UK challenger and clearing banks.

8. Regional Sub-Markets

London and the South East is the most concentrated and highly priced sub-market. London EC3 is home to Lloyd’s, the international wholesale market and most national broker headquarters. Multiples for London-based speciality and Lloyd’s wholesale brokers run at the top end of the bands above. South East regional commercial brokers (Surrey, Kent, Sussex, Berkshire) compete head-on with the national platforms for SME and middle-market commercial accounts and trade at 9x to 11x EBITDA.

Midlands (Birmingham, Solihull, Nottingham, Derby, Leicester) hosts a deep base of regional commercial brokers serving manufacturing, automotive, logistics and construction trades. The acquisition activity of JM Glendinning, Jensten, Clear Group and PIB is heavily weighted to Midlands targets. Multiples sit at the middle of the bands above, with property-portfolio and motor-trade specialists commanding a 1-turn premium.

North of England (Manchester, Leeds, Liverpool, Newcastle, Sheffield) is the heartland of the regional consolidator movement. Many of the named UK consolidators were either founded or headquartered in the North (Jensten in Sheffield via the original H&H Insurance Brokers, JM Glendinning in Leeds, Bspoke Group in Sale, PIB in Retford). Northern brokers trade at the middle of the bands above with a strong supply of family-owned 2nd and 3rd generation targets aged 55+.

Scotland has a distinct broker base regulated by the FCA but operating with significant differences around Scots-law contracts and property-insurance practices. Aon, Marsh, Lockton and Gallagher dominate the Glasgow and Edinburgh corporate market. Independent regional Scottish brokers (Bruce Stevenson, Towergate Scotland legacy books, Greenwood Moreland, Caledonian Insurance Services) command modest multiples in the 7x to 9x band given the smaller PE buyer pool and the perception of higher integration complexity.

Wales has fewer than 80 trading independent commercial brokerages by FCA Register count. Cardiff and Newport host most national platform offices. Multiples sit below the UK average at 6.5x to 8.5x for sub-£500k EBITDA targets given thin buyer competition.

Northern Ireland is a distinct regulatory and commercial market. NI commercial brokers serve a higher rural and agricultural mix, with motor and farm-combined accounts dominant. Cross-border (RoI) distribution requires either an EU passport or a separate authorisation under Central Bank of Ireland rules post-Brexit. Multiples are at a 0.5 to 1.5 turn discount to UK mainland equivalents.

Republic of Ireland (cross-border) activity has accelerated post-Brexit with Howden, Ardonagh (via the 2021 acquisition of Arachas), PIB (via the 2024 Coral Insurance deal) and Marsh all building Dublin platforms.

9. Labour / Workforce

The UK insurance broking workforce is approximately 116,000 people per ONS SIC 66.22 employment data 2025. The median annual salary for a commercial account executive is £52,500 per the BIBA / IIB salary survey 2025, with senior commercial brokers and Lloyd’s wholesale brokers earning £85,000 to £180,000 base plus 25% to 60% bonus.

Key labour and workforce considerations for transactions:

10. Working Capital + Asset Considerations

UK broker balance sheets are dominated by Insurance Broking Account (IBA) cash and debtors held under CASS 5 statutory trust or risk-transfer arrangements. The accounting treatment varies dramatically between firms and is a major area of due diligence.

Key working-capital diligence items:

Capex in UK broking is modest. Most regional brokers spend 1% to 3% of revenue on technology, lease, fit-out and vehicles combined. Modern PE-backed platforms run on Acturis (the dominant UK broking platform with approximately 50%+ market share), Open GI, Applied Epic UK or proprietary cloud-native systems. Acturis migrations from legacy systems (notably the original SSP and Misys platforms) are a frequent source of post-completion integration cost and timeline overrun.

Fixed assets are typically immaterial. Most brokers operate from leased premises, with the most aggressive cost-out playbooks targeting 30% to 50% office consolidation post-completion.

Insurer agency agreements are the broker’s commercial moat. Material insurer terms-of-business agreements (TOBAs) with Aviva, AXA, Allianz, RSA / Intact (Direct Line acquired by Aviva closed July 2024), Zurich, NIG, Ageas and the Lloyd’s facilities need to be confirmed as transferable on Change of Control. Many TOBAs include automatic termination on change-of-control or require insurer consent. Pre-bid diligence on TOBA portability is essential.

Pipeline retention warranties are a feature of most UK broker SPAs. Sellers typically warrant 90%+ retention of named top-20 clients for 12 months post-completion, with proportional purchase-price reduction or earn-out clawback for losses.

11. Why CT Acquisitions

CT Acquisitions delivers UK sell-side advisory for regional and speciality insurance brokers across the £500k to £25 million EBITDA range with a structured, evidence-led process designed for the 2026 buyer landscape.

The process opens with a regulator-readiness audit: a 4-week diligence pre-flight covering CASS 5 reconciliation status, SMCR file completeness, GIPP fair value documentation, IDD product oversight evidence, and FCA Change of Control history. Many UK broker sellers reach Heads of Terms before discovering remediable regulatory exposure that delays or derails completion. CT runs the regulator-readiness audit before the marketing process opens so the data room presents a buyer-ready story from day one.

The buyer outreach playbook is calibrated to current market reality. We map all 25+ active UK PE-backed consolidators (Ardonagh, Howden, PIB, Jensten, Specialist Risk Group, Clear, Brown & Brown UK, JM Glendinning, Acrisure UK, Partners&, NextWave, Bspoke and the regional platforms) against the seller’s book composition, regional footprint, scheme assets, binder authority value and producer mix. For speciality and Lloyd’s wholesale brokers we layer the US strategic buyer pool (Brown & Brown, Hub International, Truist, Acrisure, Higginbotham, IMA Financial). For sub-£1 million EBITDA targets we maintain a refreshed list of 60+ regional sub-consolidators that pay competitive structures without the platform-buyer earn-out tail.

The financial structuring layer addresses the BADR cliff directly. For sellers targeting completion before 5 April 2026, we run a tax-optimised completion pathway with parallel HMRC clearances on Section 135 rollover and EOT alternatives. For sellers who miss the April 2026 window, we run the autumn 2026 Budget risk analysis and structure deals with rate-change protection clauses (gross-up payments triggered by a CGT or BADR rate change between exchange and completion).

The earn-out negotiation framework has been recalibrated for 2026 market conditions. UK broker earn-outs have stretched from 24 months in 2022 to 36 to 48 months in 2025, and cash at completion has fallen from 80%+ to 60% to 75%. CT models alternative structures including A-share / B-share rollover, vendor loan notes with insurance wrappers, and equity rollover into the PE platform’s MIP to recover headline value where cash-at-completion sticker shock would otherwise reduce reserve prices.

The post-completion integration support runs for 90 days post-close, focused on insurer TOBA reconfirmation, client-retention warranty defence, working-capital peg true-up, and earn-out KPI dispute prevention.

Why CT specifically: we operate at the lower mid-market where the bulk of UK broker EBITDA actually sits, we have current process-running experience across the active consolidator buyer pool, and we structure each deal to maximise after-tax cash in the founder’s hands rather than headline enterprise value.

How CT Acquisitions runs the UK insurance broker sale mandates

CT Acquisitions is a US sell-side advisor with active cross-border M&A deal flow into the UK. Our practice connects the UK owners to: (a) the named the UK PE platforms documented above with active deal posture in your size band and sub-vertical; (b) cross-border US strategic acquirers running an international rollup thesis in your vertical; (c) UK / European PE platforms (Apax, Cinven, EQT, Bridgepoint, Hg, Inflexion, CVC, Permira, BC Partners, Hellman & Friedman, Carlyle, KKR, etc.) running cross-border platforms. The introductory conversation is confidential, NDA-protected, and walks through the band-specific buyer pool, the regulator-transfer timeline at HM Revenue & Customs (HMRC), and the tax-arbitrage structuring that determines your net-of-tax proceeds.

Frequently asked questions: selling the UK insurance broker businesses in 2026

What multiple should I expect for my the UK insurance broker business in 2026?

Multiples band, premium drivers, and discount drivers are set out in the named-buyer + multiples sections above. The headline answer: most owner-operator sub-£2M EBITDA businesses trade 3-5x SDE; mid-market £2-5M EBITDA businesses trade 4-7x EBITDA; platform-candidate £5-15M EBITDA businesses trade 6-9x; add-ons to a PE platform or public strategic trade 7-11x; and £50M+ EBITDA strategic transactions reach 9-14x depending on sub-vertical and recurring-revenue mix. The actual band for your business depends on the premium/discount drivers documented in the multiples section above.

Which PE platforms and strategic acquirers are actively acquiring the UK insurance broker businesses in 2026?

The named-buyers section above lists the 3-5 most-active acquirers in the UK for insurance broker as of mid-2026, with ownership, HQ, recent acquisitions, and approximate revenue band documented per buyer. The the UK buyer pool typically includes (a) the UK-domiciled PE platforms; (b) cross-border US or UK strategics running international rollup theses; (c) listed-company strategics on London Stock Exchange (LSE / AIM); and (d) the global PE platforms (Apax, Cinven, EQT, Bridgepoint, etc.) running cross-border platforms.

How does the HM Revenue & Customs (HMRC) regulator-transfer procedure affect my sale timeline?

The regulator-transfer procedure section above documents the specific consents, novations, or new-entity applications required for a the UK insurance broker sale. Typical timeline is 60-180 days for most industry licences; some specialised regulators (financial-services AFSL transfers, healthcare CQC/HIQA/HSE notifications, environmental EPA permits) can run 6-12 months. Pre-sale engagement with the regulator 12-18 months before LOI removes most timing risk and is the highest-ROI pre-sale workstream.

What tax-arbitrage structuring is available to the UK insurance broker sellers in 2026?

The tax-arbitrage structuring section above documents the the UK-specific levers available. For most owner-operators with 15+ year holds, the jurisdiction-specific tax relief framework can reduce effective CGT on a multi-million sale to a small fraction of headline gain. The specific arbitrage depends on: (a) ownership tenure (15+ year holds unlock the most powerful exemptions); (b) seller age (some reliefs are age-gated at 55+); (c) entity structure (share sale vs asset sale, individual vs corporate seller, holdco vs trading-company structure); (d) post-completion plans (rollover into replacement asset; super contribution; retirement). Pre-sale tax-structuring engagement with a the UK-domiciled adviser is the single highest-ROI pre-sale workstream after regulator-transfer planning.

What recent 2024-2026 dated comparable transactions in the UK insurance broker should I know about?

The recent-transactions section above lists the 1-3 most-relevant dated comparable transactions in the UK insurance broker from 2024-2026 with named buyer, named target, approximate consideration where disclosed, and source citations. These transactions anchor the multiples band that buyers will reference when underwriting your sale and are the single most-cited piece of evidence in any sell-side IM.

Does CT Acquisitions advise on cross-border M&A from the UK?

Yes — CT Acquisitions is a US sell-side advisor with active cross-border deal flow into the UK. The introductory conversation maps your trailing-12-month revenue and EBITDA in £ GBP to the band-specific buyer pool, identifies the 18-24 month pre-sale workstream priorities specific to the UK insurance broker, walks through the named buyers actively acquiring in the UK at your size band, and pre-positions the tax-arbitrage outcome that determines your net-of-tax proceeds.

CT ACQUISITIONS

Disclaimer: CT Acquisitions is not a registered broker-dealer, investment advisor, or financial service provider. We act solely as a buy-side consultant and independent sponsor source. All information provided on this website is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or investment opportunity. We do not provide legal, tax, or accounting advice. Any potential transaction is subject to due diligence and legal documentation.

© 2025 CT Acquisitions. All Rights Reserved.